Cellular distribution and expression of cortical acetylcholine receptors in aging and Alzheimer's disease
- PMID: 1776738
- DOI: 10.1111/j.1749-6632.1991.tb00215.x
Cellular distribution and expression of cortical acetylcholine receptors in aging and Alzheimer's disease
Abstract
Ligand binding studies show marked reductions of nicotinic, but not of muscarinic binding sites in Alzheimer's disease. Using monoclonal antibodies we studied immunohistochemically the expression of the respective receptor proteins in the frontal cortex of middle-aged (55 +/- 5 yr) controls, age-matched controls (73 +/- 6 yr), and patients with Alzheimer's disease (74 +/- 5 yr). Density of nicotinic cholinoceptive neurons was 8000/mm3 for middle-aged controls and 4000/mm3 for age-matched controls, but only 900/mm3 in Alzheimer's brains (p less than 0.0001). Densities of muscarinic cholinoceptive and of Nissl-stained neurons were not significantly different between the groups, pointing to a selective decrease of nicotinic receptor protein expression in cortical neurons with aging and in Alzheimer's disease.
Similar articles
-
Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease.Brain Res Bull. 1991 Nov;27(5):631-6. doi: 10.1016/0361-9230(91)90038-l. Brain Res Bull. 1991. PMID: 1756381
-
Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.Brain Res. 1987 Dec 8;436(1):62-8. doi: 10.1016/0006-8993(87)91556-3. Brain Res. 1987. PMID: 3690354
-
Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease.Neurobiol Aging. 1991 May-Jun;12(3):259-62. doi: 10.1016/0197-4580(91)90107-u. Neurobiol Aging. 1991. PMID: 1876232
-
Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies.Clin Neuropharmacol. 1990;13 Suppl 3:S73-80. doi: 10.1097/00002826-199013003-00008. Clin Neuropharmacol. 1990. PMID: 2093419 Review.
-
Cholinergic receptors in aging and Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):665-76. doi: 10.1016/0278-5846(86)90035-7. Prog Neuropsychopharmacol Biol Psychiatry. 1986. PMID: 3541056 Review.
Cited by
-
Structural basis for allosteric agonism of human α7 nicotinic acetylcholine receptors.Cell Discov. 2025 Apr 8;11(1):35. doi: 10.1038/s41421-025-00788-y. Cell Discov. 2025. PMID: 40195322 Free PMC article.
-
Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications.Toxins (Basel). 2022 Dec 27;15(1):18. doi: 10.3390/toxins15010018. Toxins (Basel). 2022. PMID: 36668838 Free PMC article. Review.
-
The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited.Front Biosci (Elite Ed). 2012 Jan 1;4(1):169-80. doi: 10.2741/367. Front Biosci (Elite Ed). 2012. PMID: 22201862 Free PMC article. Review.
-
Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics.Biochem Pharmacol. 2013 Oct 15;86(8):1133-44. doi: 10.1016/j.bcp.2013.07.032. Epub 2013 Aug 8. Biochem Pharmacol. 2013. PMID: 23933385 Free PMC article. Review.
-
Acute and chronic nicotine effects on working memory in aged rats.Psychopharmacology (Berl). 1996 Jan;123(1):88-97. doi: 10.1007/BF02246285. Psychopharmacology (Berl). 1996. PMID: 8741959
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical